Archives — Current Month (12)
Groundbreaking Biotech Company Takes Major Step Forward with Deal with Chinese Partner (10/17/2018)
Canada-based biotech company signs major deal with Chinese partner to advance groundbreaking technology in the skin and tendon rejuvenation space.
Biotech Reports Encouraging Interim Gene Therapy Data for Skin Disorder (10/17/2018)
This company's findings to date for its topical therapy candidate have encouraging implications for an orphan indication.
Tech Firm Launches Medical Cannabis User Data App, Lands Partnership (10/13/2018)
This "patient-care solution" is designed to help retailers make product recommendations.
Biotech's Antibodies Target Toxic Oligomers Implicated in Parkinson's Disease (10/11/2018)
Testing conducted as part of this Canadian company's research and development work on Parkinson's disease therapeutics has identified new potential antibody candidates.
This Biotech Is 'Harnessing the Microbiome's Therapeutic Potential' (10/10/2018)
A LifeSci Capital report presented a handful of key points about the firm.
FDA Approves Biopharma's Drug with $1.75 Billion Peak Sales Potential (10/10/2018)
An H.C. Wainwright & Co. report covered the greenlighting of two therapeutics developed by this firm, whose stock, according to the analyst, has more than fivebagger return potential.
Texas Heart Takes to the CoreoGraft (10/10/2018)
Daniel Carlson of Tailwinds Research profiles Hancock Jaffe Laboratories, which is partnering with the Texas Heart Institute to further develop an innovative graft designed for use in coronary bypass surgery.
Developer of Nitric Oxide Delivery Devices Rebrands to Focus on Leading Advancements (10/09/2018)
This Utah-based company rolled out an online campaign that highlights its strategic repositioning.
DURECT Receives Return on Schizophrenia Drug Approval (10/03/2018)
A new, once-monthly injectable treatment for schizophrenia uses patents of a small-cap, U.S.-based pharmaceutical firm.
Company with Cancer Radiotherapy Grows Revenue for Six Consecutive Quarters (10/03/2018)
An H.C. Wainwright & Co. report reviewed this company's Q4/18 earnings and opportunities for increasing it.
Surgical Robotics Developer Demonstrates Technology at Medical Conference (10/03/2018)
A Ladenburg Thalmann report relayed how this Massachusetts company participated at the Transcatheter Cardiovascular Therapeutics annual meeting through a live transmission—the first ever—of a remote interventional procedure using the CorPath GRX system.
Stock in Vanguard of Drive to Phase Out Antibiotics in Animal Feed (10/01/2018)
As the worldwide movement to ban antibiotics as a growth promoter in animal feed gains traction, technical analyst Clive Maund has called an "immediate strong buy" on a company that has developed an alternative.
More Archives
2018Sep Aug Jul Jun May Apr Mar Feb Jan
2017Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2016Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2015Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
